diet and cancer 2:378–380, 379 t,
382
diet and cardiovascular health
2:49–50
cardiomyopathy 2: 33
cholesterol blood levels 2: 37
DASH eating plan 2:47
hypertension 2:66–67
lifestyle and cardiovascular
health 2:72–73
omega fatty acids and
cardiovascular health 2:90
Ornish program 2:91–92
soy and cardiovascular health
2:106
triglyceride blood level 2:112
diet and health 3:44, 90; 4:19,
28–29, 174, 175, 182
dietary supplement 4:73, 97, 169,
196
dieting 4: 185 , 293–294, 295
digestion 1:366; 4:176, 284
digestive enzymes 3:34–35; 4: 120
digestive hormones 3: 35
duodenum 3: 36
gastrointestinal system 3: 3
insulin 3: 148
islets of Langerhans 3: 149
malabsorption 3: 77
pancreas 3: 79
small bowel transplantation
3: 89
somatostatin 3: 159
stomach 3: 90
stomach cancer 3: 90
digestive hormones 3:35; 4: 178
digestive enzymes 3: 35
gallbladder 3: 46
gastrointestinal system 3:1, 3
glucagon 3: 128
glucose 3: 128
H2 antagonist medications 3: 59
insulin 3: 148
pancreas 3: 79
small bowel transplantation
3: 89
digestive system. Seegastrointestinal
system
digitalis 2:76, 81; 4: 145
digital rectal examination (DRE)
3:35, 54 , 86 , 249
digoxin 2:76, 81, 114; 4:145, 153
dilation and curettage (D&C)
3:268, 275
diphenhydramine (Benadryl) 1:25,
206; 2:243, 267
diphtheria 1:6; 2: 298 , 322; 4:4, 17
diploid cell 4:127, 140, 144
diplopia 1:86, 86 t, 94 , 118
disability and exercise 2:194, 203;
4:220
disaccharide 4:185, 191
discoid lupus erythematosus (DLE)
1:152–153, 153 t
disease-modifying antirheumatic
drugs (DMARDs) 1:302, 357;
2:258–259, 258 t, 270 , 276
dislocations 1:320
disseminated intravascular
coagulation (DIC) 2: 130 , 137,
172, 357
dissociative amnesia 3:359, 372
dissociative disorder 3:372–373,
381 , 385
disulfiram 4:315, 320, 333, 354
Ditropan. Seeoxybutynin
diuretic 2:76, 80–81, 85t,99; 4:73,
194, 293
diverticular disease 3:35–36, 36 t,
65
DMARDs. Seedisease-modifying
antirheumatic drugs
DNA (deoxyribonucleic acid)
2:119, 361, 362, 375, 376, 388;
3:57, 244; 4: 109 , 122, 192
domestic violence 4:244, 245
dong quai 1:366; 4:66–67, 67 t, 83 ,
95
dopamine 3:124
adrenal glands 3:107, 108
aging and neurologic changes
1: 221
alcohol 4:316, 317
aldosterone 3: 112
antidepressant medications
3: 361
antipsychotic medications 3: 363
delirium tremens 4: 330
dystonia 1: 320
ECT 3: 375
endocrine system 3: 99
epinephrine 3: 126
hypothalamus 3: 145
integumentary system 1: 127
midbrain 1: 232
nervous system 1: 217
neurotransmitter 1: 272
nevus 1: 178
nicotine 4: 345
norepinephrine 3: 152
Parkinson’s disease 1: 275
pheochromocytoma 3: 154SAMe 4: 97
tobacco 4: 353
dorsal ganglia 1:361, 382
dosage 4:154
dextromethorphan 4: 332
OTC drug 4: 166
peak level 4: 168
therapeutic level 4: 172
therapeutic window 4: 172
tolerance 4: 354
vitamin and mineral therapy
4: 105
dose 4:154
double vision. Seediplopia
Down syndrome 1:16; 2:37, 38, 40,
59, 63, 160; 4:122–123, 123 t
autosomal trisomy 4: 114
birth defects 4: 9
chromatid 4: 117
chromosomal disorders 4: 117
chromosome 4: 119
genetics and molecular medicine
4: 111
mosaicism 4:134–135
replication error 4: 139
doxycycline 2:335, 336, 350, 356
DRE. Seedigital rectal examination
drinking water standards 4:17, 18,
19–21, 20 t, 41
drug dosage 4:159, 318
drug interaction 1:365, 366; 2:76,
309, 367; 4:154–157, 155 t–157t
aging and drug metabolism/drug
response 4: 149
hypericum 4: 99
nutritional supplements 4: 196
OTC drug 4: 167
TCM 4:102–103
vitamin and mineral therapy
4: 105
yohimbe 4: 107
zeaxanthin 4: 107
drug resistance 2:305, 360. See also
antibiotic resistance
drug(s) 4:145–173
dry eye syndrome 1:76, 79, 86
DTH (delayed-type
hypersensitivity) reaction. See
type IV hypersensitivity reaction
DUB. Seedysfunctional uterine
bleeding
Duchenne’s muscular dystrophy
1:337, 338t
ductus arteriosus 2:10, 38
duodenum 3:36–37; 4: 286
bowel atresia 3: 20Index 465